BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2814484
Number of visits today
224
Number of downloads
2064808
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Xiao X, Luo Y, Peng D. Updated Understanding of the Crosstalk Between Glucose/Insulin and Cholesterol Metabolism. Front Cardiovasc Med 2022;9:879355. [DOI: 10.3389/fcvm.2022.879355] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Fenton NM, Nguyen TB, Sharpe LJ, Brown AJ. Refining sugar's involvement in cholesterol synthesis. Biochim Biophys Acta Mol Cell Biol Lipids 2023;1868:159266. [PMID: 36528253 DOI: 10.1016/j.bbalip.2022.159266] [Reference Citation Analysis]
2 Nakamura A, Aida Y, Okamoto M, Maeda A, Nagao A, Kitatani K, Takekoshi S, Fujisawa A, Yamamoto Y, Kashiba M. Transferrin, insulin, and progesterone modulate intracellular concentrations of coenzyme Q and cholesterol, products of the mevalonate pathway, in undifferentiated PC12 cells. J Clin Biochem Nutr 2023. [DOI: 10.3164/jcbn.22-115] [Reference Citation Analysis]
3 Lee J, Kim MH, Lee JM, Chang SA. Does Pitavastatin Therapy for Patients with Type 2 Diabetes and Dyslipidemia Affect Serum Adiponectin Levels and Insulin Sensitivity? J Clin Med 2022;11. [PMID: 36431233 DOI: 10.3390/jcm11226756] [Reference Citation Analysis]
4 Biolo G, Vinci P, Mangogna A, Landolfo M, Schincariol P, Fiotti N, Mearelli F, Di Girolamo FG. Mechanism of action and therapeutic use of bempedoic acid in atherosclerosis and metabolic syndrome. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.1028355] [Reference Citation Analysis]
5 Ruscica M, Sirtori CR, Carugo S, Banach M, Corsini A. Bempedoic Acid: for Whom and When. Curr Atheroscler Rep 2022. [PMID: 35900636 DOI: 10.1007/s11883-022-01054-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345